Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: From mouse to man

C. L. Fang, L. J. Yin, S. Sharma, S. Kierstein, H. F. Wu, G. Eid, Angela Franciska Haczku, C. J. Corrigan, S. Ying

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: RELM-β has been implicated in airways inflammation and remodelling in murine models. Its possible functions in human airways are largely unknown. The aim was to address the hypothesis that RELM-β plays a role in extracellular matrix deposition in asthmatic airways. Methods: The effects of RELM-β gene deficiency were studied in a model of allergen exposure in mice sensitised and challenged with Aspergillus fumigatus (Af). RELM-β expression was investigated in bronchial biopsies from asthmatic patients. Direct regulatory effects of RELM-β on human lung fibroblasts were examined using primary cultures and the MRC5 cell line in vitro. Results: Sensitisation and challenge of wild-type mice with Af-induced release of RELM-β with a time course coincident with that of procollagen in the airways. Af-induced expression of mRNA encoding some, but not all ECM in the lung parenchyma was attenuated in RELM-β-/- mice. RELM-β expression was significantly increased in the bronchial submucosa of human asthmatics compared with controls, and its expression correlated positively with that of fibronectin and α-smooth muscle actin. In addition to epithelial cells, macrophages, fibroblasts and vascular endothelial cells formed the majority of cells expressing RELM-β in the submucosa. Exposure to RELM-β increased TGF-β1, TGF-β2, collagen I, fibronectin, smooth muscle α-actin, laminin α1, and hyaluronan and proteoglycan link protein 1 (Hapl1) production as well as proliferation by human lung fibroblasts in vitro. These changes were associated with activation of ERK1/2 in MRC5 cells. Conclusion: The data are consistent with the hypothesis that elevated RELM-β expression in asthmatic airways contributes to airways remodelling at least partly by increasing fibroblast proliferation and differentiation with resulting deposition of extracellular matrix proteins.

Original languageEnglish (US)
Pages (from-to)940-952
Number of pages13
JournalClinical and Experimental Allergy
Volume45
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Resistin
Asthma
Fibroblasts
Aspergillus fumigatus
Airway Remodeling
Fibronectins
Lung
Smooth Muscle
Actins
Procollagen
Extracellular Matrix Proteins
Proteoglycans
Hyaluronic Acid
Allergens
Extracellular Matrix
Collagen
Endothelial Cells
Epithelial Cells
Macrophages

Keywords

  • Asthma
  • Collagen
  • Fibronectin
  • RELM-β
  • Remodelling
  • TGF-β

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma : From mouse to man. / Fang, C. L.; Yin, L. J.; Sharma, S.; Kierstein, S.; Wu, H. F.; Eid, G.; Haczku, Angela Franciska; Corrigan, C. J.; Ying, S.

In: Clinical and Experimental Allergy, Vol. 45, No. 5, 01.05.2015, p. 940-952.

Research output: Contribution to journalArticle

Fang, C. L. ; Yin, L. J. ; Sharma, S. ; Kierstein, S. ; Wu, H. F. ; Eid, G. ; Haczku, Angela Franciska ; Corrigan, C. J. ; Ying, S. / Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma : From mouse to man. In: Clinical and Experimental Allergy. 2015 ; Vol. 45, No. 5. pp. 940-952.
@article{d582fc542bdb4ea089c7852c242a6555,
title = "Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: From mouse to man",
abstract = "Background: RELM-β has been implicated in airways inflammation and remodelling in murine models. Its possible functions in human airways are largely unknown. The aim was to address the hypothesis that RELM-β plays a role in extracellular matrix deposition in asthmatic airways. Methods: The effects of RELM-β gene deficiency were studied in a model of allergen exposure in mice sensitised and challenged with Aspergillus fumigatus (Af). RELM-β expression was investigated in bronchial biopsies from asthmatic patients. Direct regulatory effects of RELM-β on human lung fibroblasts were examined using primary cultures and the MRC5 cell line in vitro. Results: Sensitisation and challenge of wild-type mice with Af-induced release of RELM-β with a time course coincident with that of procollagen in the airways. Af-induced expression of mRNA encoding some, but not all ECM in the lung parenchyma was attenuated in RELM-β-/- mice. RELM-β expression was significantly increased in the bronchial submucosa of human asthmatics compared with controls, and its expression correlated positively with that of fibronectin and α-smooth muscle actin. In addition to epithelial cells, macrophages, fibroblasts and vascular endothelial cells formed the majority of cells expressing RELM-β in the submucosa. Exposure to RELM-β increased TGF-β1, TGF-β2, collagen I, fibronectin, smooth muscle α-actin, laminin α1, and hyaluronan and proteoglycan link protein 1 (Hapl1) production as well as proliferation by human lung fibroblasts in vitro. These changes were associated with activation of ERK1/2 in MRC5 cells. Conclusion: The data are consistent with the hypothesis that elevated RELM-β expression in asthmatic airways contributes to airways remodelling at least partly by increasing fibroblast proliferation and differentiation with resulting deposition of extracellular matrix proteins.",
keywords = "Asthma, Collagen, Fibronectin, RELM-β, Remodelling, TGF-β",
author = "Fang, {C. L.} and Yin, {L. J.} and S. Sharma and S. Kierstein and Wu, {H. F.} and G. Eid and Haczku, {Angela Franciska} and Corrigan, {C. J.} and S. Ying",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/cea.12481",
language = "English (US)",
volume = "45",
pages = "940--952",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma

T2 - From mouse to man

AU - Fang, C. L.

AU - Yin, L. J.

AU - Sharma, S.

AU - Kierstein, S.

AU - Wu, H. F.

AU - Eid, G.

AU - Haczku, Angela Franciska

AU - Corrigan, C. J.

AU - Ying, S.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background: RELM-β has been implicated in airways inflammation and remodelling in murine models. Its possible functions in human airways are largely unknown. The aim was to address the hypothesis that RELM-β plays a role in extracellular matrix deposition in asthmatic airways. Methods: The effects of RELM-β gene deficiency were studied in a model of allergen exposure in mice sensitised and challenged with Aspergillus fumigatus (Af). RELM-β expression was investigated in bronchial biopsies from asthmatic patients. Direct regulatory effects of RELM-β on human lung fibroblasts were examined using primary cultures and the MRC5 cell line in vitro. Results: Sensitisation and challenge of wild-type mice with Af-induced release of RELM-β with a time course coincident with that of procollagen in the airways. Af-induced expression of mRNA encoding some, but not all ECM in the lung parenchyma was attenuated in RELM-β-/- mice. RELM-β expression was significantly increased in the bronchial submucosa of human asthmatics compared with controls, and its expression correlated positively with that of fibronectin and α-smooth muscle actin. In addition to epithelial cells, macrophages, fibroblasts and vascular endothelial cells formed the majority of cells expressing RELM-β in the submucosa. Exposure to RELM-β increased TGF-β1, TGF-β2, collagen I, fibronectin, smooth muscle α-actin, laminin α1, and hyaluronan and proteoglycan link protein 1 (Hapl1) production as well as proliferation by human lung fibroblasts in vitro. These changes were associated with activation of ERK1/2 in MRC5 cells. Conclusion: The data are consistent with the hypothesis that elevated RELM-β expression in asthmatic airways contributes to airways remodelling at least partly by increasing fibroblast proliferation and differentiation with resulting deposition of extracellular matrix proteins.

AB - Background: RELM-β has been implicated in airways inflammation and remodelling in murine models. Its possible functions in human airways are largely unknown. The aim was to address the hypothesis that RELM-β plays a role in extracellular matrix deposition in asthmatic airways. Methods: The effects of RELM-β gene deficiency were studied in a model of allergen exposure in mice sensitised and challenged with Aspergillus fumigatus (Af). RELM-β expression was investigated in bronchial biopsies from asthmatic patients. Direct regulatory effects of RELM-β on human lung fibroblasts were examined using primary cultures and the MRC5 cell line in vitro. Results: Sensitisation and challenge of wild-type mice with Af-induced release of RELM-β with a time course coincident with that of procollagen in the airways. Af-induced expression of mRNA encoding some, but not all ECM in the lung parenchyma was attenuated in RELM-β-/- mice. RELM-β expression was significantly increased in the bronchial submucosa of human asthmatics compared with controls, and its expression correlated positively with that of fibronectin and α-smooth muscle actin. In addition to epithelial cells, macrophages, fibroblasts and vascular endothelial cells formed the majority of cells expressing RELM-β in the submucosa. Exposure to RELM-β increased TGF-β1, TGF-β2, collagen I, fibronectin, smooth muscle α-actin, laminin α1, and hyaluronan and proteoglycan link protein 1 (Hapl1) production as well as proliferation by human lung fibroblasts in vitro. These changes were associated with activation of ERK1/2 in MRC5 cells. Conclusion: The data are consistent with the hypothesis that elevated RELM-β expression in asthmatic airways contributes to airways remodelling at least partly by increasing fibroblast proliferation and differentiation with resulting deposition of extracellular matrix proteins.

KW - Asthma

KW - Collagen

KW - Fibronectin

KW - RELM-β

KW - Remodelling

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=84927713505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927713505&partnerID=8YFLogxK

U2 - 10.1111/cea.12481

DO - 10.1111/cea.12481

M3 - Article

C2 - 25545115

AN - SCOPUS:84927713505

VL - 45

SP - 940

EP - 952

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 5

ER -